The Genomenon team is looking forward to seeing many of you in Denver, Colorado for the ASHG 2024 Annual Meeting. We have a number of activities during the conference to meet with friends and partners and share more about how we combine our AI and team of experts to deliver the best of genomic intelligence.
Co-Lab Session
Advances in genomic testing have transformed medical genetics, revealing insights into various diseases. Whole genome and exome sequencing are increasingly used in clinical settings, necessitating the interpretation of genetic variants with potential clinical implications.
The American College of Medical Genetics and Genomics (ACMG) established guidelines for managing secondary findings, impacting patients, families, and laboratories. These recommendations include a curated list of actionable genes for diagnostic reports. Genomenon recently completed a comprehensive curation of ACMG Secondary Findings genes, empowering labs to support informed clinical decisions and to automate the incorporation of these findings into workflows.
Join us to hear our discussion on ACMG secondary findings guidelines, best practices for implementation, and the critical role of curated evidence in diagnostic results and patient outcomes.
Dr. Mark Kiel
Genomenon Founder and CSO
Jeffrey Bissonnette
Senior Director of Genomic Curation
Scientific Posters
Wednesday, November 6, 2024, 2:30PM - 4:30PM
Exhibit & Poster Hall, Hall F / Poster number 1058W
Presenting Author: Mark J. Kiel, MD, PhD
Thursday, November 7, 2024, 2:30PM - 4:30PM
Exhibit & Poster Hall, Hall F / Poster number: 3075TFirst
Presenting Author:: Jeffrey Bissonnette, MSC, CGC